Chizuko Koseki
President and CEO
vetnary
Livtech Inc.
Japan
Biography
Chizuko is currently focusing on successful expansion of TAGCyx Biotechnolgies' business as a representative director COO. Chizuko is a founder and director of transB Ltd. I was also a board of director of Stelic Institute & Co., Tokyo-based privately owned Japanese biotech company until Nov 2008. Former to founding transB Ltd., I worked as a vice president of Sosei Co. Ltd (4565, MOTHERS index) based in its UK operation for 8 years. I played a major role in establishing its unique business model, drug reprofiling platform (DRP®). For this role, I made business model written on paper to practically running active business. Prior to joining Sosei, I was working based in the UK as a consultant for various Japanese health care companies. Formerly, I held various positions as a researcher including a section chief in National Cardiovascular Research Institute (Japan), a visiting scientist in Colombia and Florida universities (USA), and an associate professor in Tokyo University (Japan). Holding Ph.D in pharmacology from Tokyo University, Medical department.
Research Interest
Cardilogy